Clinical Trial Update: FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FOLFOX with Botensilimab and Balstilimab for localized rectal cancer before surgery is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• Balstilimab (balstilimab)
• Botensilimab (botensilimab)
• FOLFOX regimen (folinic acid (leucovorin) + fluorouracil + oxaliplatin)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Rectal Adenocarcinoma, Stage IIA Rectal Cancer AJCC v8 | Phase 2 | Status: RECRUITING